Table 2.

Risk baseline factors for mortality analyzed by Cox regression model.

Variable	Mortality (95%CI))	HR (95% CI)	P	aHR (95% CI)	P
Age at diagnosis (years old)
∼5	0.045(0.110, 0.608)	1.0		1.0
∼12	0.081(0.600, 1.831)	3.070 (1.301, 7.245)	0.010	3.140 (1.331, 7.411)	0.009
∼18	0.944(-0.373, 6.037)	5.528 (1.454, 21.012)	0.012	5.451 (1.434, 20.724)	0.013
Age at ART initiation (years old)
∼5	0.072(0.087, 0.782)	1.0
∼12	0.051(0.304, 1.027)	1.338 (0.508, 3.522)	0.555
∼18	0.367(0.666, 4.476)	4.139 (1.377, 12.441)	0.011
ART site
CDC based	0.072(0.322, 1.253)	1.0
Hospital based	0.045(0.335, 1.022)	0.691 (0.317, 1.508)	0.354
Baseline Disclosure
Yes	0.185(0.831, 3.231)	3.502 (1.605, 7.642)	0.002
No	0.033(0.217, 0.696)	1.0
WHO clinical stages
I	0.077(0.048, 0.727)	1.0
II	0.179(0.014, 1.416)	1.911 (0.513, 7.118)	0.334
III	0.073(0.276, 1.177)	2.193 (0.749, 6.419)	0.152
IV	0.262(0.475, 3.19)	5.490 (1.742, 17.304)	0.003
ART regimens
AZT+3TC + LPV/r	0.070(0.265, 1.131)	1.0
D4T+3TC + LPV/r	1.017(-0.785, 4.851)	3.532 (0.774, 16.127)	0.103
AZT+3TC + EFV/NVP	0.076(0.188, 1.035)	1.034 (0.408, 2.624)	0.943
D4T+3TC + EFV/NVP	0.458(-0.44, 1.356)	0.857 (0.109, 6.701)	0.883
ABC+3TC + LPV/r	0.182(0.112, 1.708)	1.139 (0.389, 3.335)	0.813
Baseline CD4+T cell count
Low	0.121(-0.116, 0.358)	10.964 (1.459, 82.390)	0.020	8.309 (1.093, 63.135)	0.041
Medium	0.075(0.185, 1.018)	4.977 (0.622, 39.800)	0.130	4.146 (0.416, 33.318)	0.181
High	0.074(0.659, 1.854)	1.0		1.0
Baseline CD4+T cell percentage (%)
<15	0.090(0.404, 1.57)	1.0
≥15	0.040(0.297, 0.906)	0.574 (0.264, 1.250)	0.162
Baseline VL (copies/ml)
<1000	0.433(-0.171, 2.768)	1.0
<100000	0.105(0.126, 1.132)	0.499 (0. 124, 1.997)	0.326
≥100000	0.041(0.368, 1.035)	2.941 (0.171, 1.994)	0.391
Period from diagnosis to ART (days)
≤14	0.226(0.140, 2.121)	1.0
>14	0.033(0.376, 0.963)	0.567 (0.212, 1.512)	0.257